Integrative Analysis of the AMPK subunits in Colorectal Adeno Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• 5-adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a promising therapeutic target for cancer treatment.
• The complex and dual nature of AMPK presents challenges for effective therapeutic strategies.
• Investigating the seven subunits and twelve isoforms of AMPK in colorectal adenocarcinoma is crucial for understanding its role.

Purpose of the Study:

• To conduct an integrative analysis of AMPK subunits and isoforms in colorectal adenocarcinoma patients.
• To explore the differential expression, methylation status, and protein-protein interactions of AMPK in COAD.
• To determine the clinical significance of AMPK expression in colorectal cancer.

Main Methods:

• Utilized web-based bioinformatics tools: UALCAN, Timer 2.0, KM Plotter, cBioPortal, COSMIC, and STRING.
• Analyzed differential mRNA and protein expression of AMPK subunits.
• Investigated promoter methylation, survival data, and protein-protein interactions.

Main Results:

• AMPK subunit mRNA expression is upregulated in Colorectal Adeno Carcinoma (COAD), but protein expression is reduced.
• Specific subunits, α2 and β2, showed significantly decreased protein levels in COAD patients.
• The γ3 subunit exhibited hypermethylation in colon tumors, and Liver Kinase B1 mutations may contribute to AMPK downregulation.

Conclusions:

• AMPK expression is generally beneficial in cancer, despite complex regulatory mechanisms observed in COAD.
• The findings highlight the intricate role of AMPK in colorectal adenocarcinoma.
• Further research into AMPK's subunits and isoforms could lead to novel cancer treatment strategies.